Cardiac MRI right atrial area measurement thresholds for risk stratification in patients with PAH
F. Alandejani ( Sheffield, United Kingdom), E. Tubman ( Sheffield, United Kingdom), Y. Shahin ( Sheffield, United Kingdom), R. Lewis ( Sheffield, United Kingdom), K. Dwivedi ( Sheffield, United Kingdom), D. Alkhanfar ( Sheffield, United Kingdom), S. Alabed ( Sheffield, United Kingdom), C. Johns ( Sheffield, United Kingdom), P. Garg ( Sheffield, United Kingdom), R. Condliffe ( Sheffield, United Kingdom), A. Lawrie ( Sheffield, United Kingdom), J. Wild ( Sheffield, United Kingdom), D. Kiely ( Sheffield, United Kingdom), A. Swift ( Sheffield, United Kingdom)
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Alandejani ( Sheffield, United Kingdom), E. Tubman ( Sheffield, United Kingdom), Y. Shahin ( Sheffield, United Kingdom), R. Lewis ( Sheffield, United Kingdom), K. Dwivedi ( Sheffield, United Kingdom), D. Alkhanfar ( Sheffield, United Kingdom), S. Alabed ( Sheffield, United Kingdom), C. Johns ( Sheffield, United Kingdom), P. Garg ( Sheffield, United Kingdom), R. Condliffe ( Sheffield, United Kingdom), A. Lawrie ( Sheffield, United Kingdom), J. Wild ( Sheffield, United Kingdom), D. Kiely ( Sheffield, United Kingdom), A. Swift ( Sheffield, United Kingdom). Cardiac MRI right atrial area measurement thresholds for risk stratification in patients with PAH. 1522
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: